Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Williams Website

Kirsten M. Williams, M.D.

Selected Publications

1)  Williams KM, Chien JW, Gladwin MT, Pavletic SZ.
Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.
JAMA. 302: 306-14, 2009.
2)  Williams KM, Lucas PJ, Bare CV, Wang J, Chu YW, Tayler E, Kapoor V, Gress RE.
CCL25 increases thymopoiesis after androgen withdrawal.
Blood. 112: 3255-63, 2008.
3)  Williams KM, Hakim FT, Gress RE.
T cell immune reconstitution following lymphodepletion.
Semin. Immunol. 19: 318-30, 2007.
4)  Norman BC, Jacobsohn DA, Williams KM, Au BK, Au MA, Lee SJ, Moravec CK, Chien JW.
Fluticasone, azithromycin and montelukast therapy in reducing corticosteroid exposure in bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: a case series of eight patients.
Bone Marrow Transplant. 46: 1369-73, 2011.
5)  Chien JW, Duncan S, Williams KM, Pavletic SZ.
Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease.
Biol. Blood Marrow Transplant. 16: S106-14, 2010.
6)  Williams KM, Hnatiuk O, Mitchell SA, Baird K, Gadalla SM, Steinberg SM, Shelhamer J, Carpenter A, Avila D, Taylor T, Grkovic L, Pulanic D, Comis LE, Blacklock-Schuver B, Gress RE, Pavletic SZ.
NHANES III equations enhance early detection and mortality prediction of bronchiolitis obliterans syndrome after hematopoietic SCT.
Bone Marrow Transplant. 49: 561-6, 2014.
7)  Bassim CW, Fassil H, Mays JW, Edwards D, Baird K, Steinberg SM, Williams KM, Cowen EW, Mitchell SA, Cole K, Taylor T, Avila D, Zhang D, Pulanic D, Grkovic L, Fowler D, Gress RE, Pavletic SZ.
Validation of the National Institutes of Health chronic GVHD Oral Mucosal Score using component-specific measures.
Bone Marrow Transplant. 49: 116-21, 2014.
8)  Baird K, Steinberg SM, Grkovic L, Pulanic D, Cowen EW, Mitchell SA, Williams KM, Datiles MB, Bishop R, Bassim CW, Mays JW, Edwards D, Cole K, Avila DN, Taylor T, Urban A, Joe GO, Comis LE, Berger A, Stratton P, Zhang D, Shelhamer JH, Gea-Banacloche JC, Sportes C, Fowler DH, Gress RE, Pavletic SZ.
National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis.
Biol. Blood Marrow Transplant. 19: 632-9, 2013.
9)  Gadalla SM, Sales-Bonfim C, Carreras J, Alter BP, Antin JH, Ayas M, Bodhi P, Davis J, Davies SM, Deconinck E, Deeg HJ, Duerst RE, Fasth A, Ghavamzadeh A, Giri N, Goldman FD, Kolb EA, Krance R, Kurtzberg J, Leung WH, Srivastava A, Or R, Richman CM, Rosenberg PS, Toledo Codina JS, Shenoy S, Socié G, Tolar J, Williams KM, Eapen M, Savage SA.
Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita.
Biol. Blood Marrow Transplant. 19: 1238-43, 2013.
10)  Grkovic L, Baird K, Steinberg SM, Williams KM, Pulanic D, Cowen EW, Mitchell SA, Hakim FT, Martires KJ, Avila DN, Taylor TN, Salit RB, Rowley SD, Zhang D, Fowler DH, Bishop MR, Gress RE, Pavletic SZ.
Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity.
Leukemia. 26: 633-43, 2012.
11)  Williams KM, Ostrow LW, Loeb DM, Chung T, Cohn RD, Corse AM, Mammen AL, Chen AR.
Immunohistochemistry of affected tissue may guide cGVHD treatment decisions.
Bone Marrow Transplant. 47: 731-3, 2012.
12)  Fassil H, Bassim CW, Mays J, Edwards D, Baird K, Steinberg SM, Williams KM, Cowen EW, Mitchell SA, Hakim FT, Taylor T, Avila D, Zhang D, Grkovic L, Datiles M, Gress RE, Pavletic SZ.
Oral chronic graft-vs.-host disease characterization using the NIH scale.
J. Dent. Res. 91: 45S-51S, 2012.
13)  Martires KJ, Baird K, Steinberg SM, Grkovic L, Joe GO, Williams KM, Mitchell SA, Datiles M, Hakim FT, Pavletic SZ, Cowen EW.
Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease.
Blood. 118: 4250-7, 2011.
14)  Williams K, Gress R.
Lazarus H, Laughlin M, eds.
Immune Reconstitution Following Allogeneic Stem Cell Transplant. In: Allogeneic Stem Cell Transplantation. Volume Chapter 31, 2nd edition.
New York: Humana Press; 2010. p. 545-64 [Book Chapter]
15)  Williams K, Chu Y, Gress R.
Chou-Chik T, Yang Y, eds.
The Influence of Cytokines on the Life and Death of T Lymphocytes in Physiologic Environment and in Patients with Immune Disorders: Cancer, Viral Infections, or Autoimmunity. In: The Life and Death of T Lymphocytes - The Influence of Cytokines under Physiological and Pathological Conditions. Volume 1st edition.
Kerala, India: Transworld Research Network; 2010. p. 217-39 [Book Chapter]
16)  Williams KM, Agwu AL, Dabb AA, Higman MA, Loeb DM, Valsamakis A, Chen AR.
A clinical algorithm identifies high risk pediatric oncology and bone marrow transplant patients likely to benefit from treatment of adenoviral infection.
J. Pediatr. Hematol. Oncol. 31: 825-31, 2009.
17)  Williams KM, Mella H, Lucas PJ, Williams JA, Telford W, Gress RE.
Single cell analysis of complex thymus stromal cell populations: rapid thymic epithelia preparation characterizes radiation injury.
Clin Transl Sci. 2: 279-85, 2009.
18)  Williams KM, Gress RE.
Immune reconstitution and implications for immunotherapy following haematopoietic stem cell transplantation.
Best Pract Res Clin Haematol. 21: 579-96, 2008.
19)  Williams KM, Higman MA, Chen AR, Schwartz CL, Wharam M, Colombani P, Arceci RJ.
Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma.
Pediatr Blood Cancer. 50: 667-70, 2008.
20)  Aragon-Ching JB, Williams KM, Gulley JL.
Impact of androgen-deprivation therapy on the immune system: implications for combination therapy of prostate cancer.
Front. Biosci. 12: 4957-71, 2007.
Click Here to View Collapsed Bibliography.

This page was last updated on 6/17/2014.